aTyr Pharma reported $2.55M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Ardelyx USD 133.3M 6.04M Jun/2026
aTyr Pharma USD 2.55M 126.72K Jun/2026
Biogen USD 2.32B 663.6M Sep/2026
Bristol-Myers Squibb USD 23.4B 1.08B Sep/2026
Cipla INR 63.61B 1.3B Sep/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.44M 246K Jun/2026
CSL USD 5.7B 2.82B Dec/2025
Curis USD 11.52M 2.5M Mar/2026
GlaxoSmithKline GBP 6.03B 227M Sep/2026
Grifols EUR 1.99B 217.4M Dec/2025
Lakefront Biotherapeutics EUR 48.75M 6.87M Sep/2026
Novartis USD 9.88B 325M Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
United Therapeutics USD 6.28B 124.3M Sep/2026